SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Investment analysts at National Bank Financial dropped their Q2 2025 EPS estimates for shares of SNC-Lavalin Group in a report released on Thursday, March 13th. National Bank Financial analyst M. Sytchev now forecasts that the company will post earnings of $0.65 per share for the quarter, down from their prior estimate of $0.77. National Bank Financial also issued estimates for SNC-Lavalin Group’s Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.89 EPS and FY2026 earnings at $3.49 EPS.
Separately, Stifel Canada raised shares of SNC-Lavalin Group to a “strong-buy” rating in a report on Tuesday, February 4th.
SNC-Lavalin Group Price Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
See Also
- Five stocks we like better than SNC-Lavalin Group
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Short Selling – The Pros and Cons
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Short a Stock in 5 Easy Steps
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
